Trial · NCT06795672
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Trail Making Test Part B (TMT-B) | From enrollment to the end of treatment and 2 months until the end of treatment | Used as a measure of attentional set-shifting and mental flexibility. Time needed to complete the tasks is recorded. |
| Secondary | The Trail Making Test - A (TMT-A) | From enrollment to the end of treatment and 2 months until the end of treatment | Used as a measure of psychomotor speed and visual search/attention skills |
| Secondary | 15 Words of Rey | From enrollment to the end of treatment and 2 months until the end of treatment | To assess verbal learning ability and long-term verbal memory (IMMEDIATE RECALL: score ranging from 0 to 75. DELAYED RECALL: score ranging from 0 to 15). |
| Secondary | Memory with interference - ENB 2 | From enrollment to the end of treatment and 2 months until the end of treatment | to assess working memory through the memorization of letter triplets alongside a distracting task lasting 10 seconds in the first part and 30 seconds in the second. The maximum obtainable score is 9 for both parts of the test. |
| Secondary | Dual task test | From enrollment to the end of treatment and 2 months until the end of treatment | Dual Task to assess the ability to perform two tasks simultaneously (one verbal and one visuomotor) |
| Secondary | Elithorn's Perceptual Maze Test | From enrollment to the end of treatment and 2 months until the end of treatment | to investigate problem-solving abilities. |
| Secondary | Stroop Test | From enrollment to the end of treatment and 2 months until the end of treatment | to assess the speed and accuracy of automatic response inhibition. |
| Secondary | Functional Independence Measure (FIM) | From enrollment to the end of treatment and 2 months until the end of treatment | To evaluate the degree of disability. |
| Secondary | Hospital Anxiety and Depression Scale | From enrollment to the end of treatment and 2 months until the end of treatment | to assess the presence of depression and anxiety. |
| Secondary | Short Form Health Survey 36 (SF-36) | From enrollment to the end of treatment and 2 months until the end of treatment | to evaluate quality of life. |
| Secondary | Feasibility, Satisfaction, and Cost Questionnaire | From enrollment to the end of treatment and 2 months until the end of treatment | to assess the feasibility and satisfaction with the treatment and to evaluate the costs associated with it. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06795672/registered